Case report 24 th Summer School of Internal Medicine 2015

Size: px
Start display at page:

Download "Case report 24 th Summer School of Internal Medicine 2015"

Transcription

1 Case report 24 th Summer School of Internal Medicine 2015 Goldmannová D., Horák P., Skácelová M. IIIrd Internal Clinic - endocrinology, diabetology, rheumatology, nephrology University hospital Olomouc, Czech Republic

2 Case report Woman, birth on 1980, send from District Department of internal medicine She was accepted for collapse, serious anemia, thrombocytopenia, progression of renal insufficiency, pleural pain in 12/14 Antiphospholipid syndrome (pos. LAC, ACLA, B2Gl, recurrent deep vein thrombosis, pulmonary embolism) diagnosed 9/14 Focal segmental glomerolosclerosis (with renal insufficiency stable creatinine around 100µmol/l) diagnosed in her 10 years Anamnestically positive ANA, anti-dsdna, ANCA, fleeting pulmonary infiltrates (X-ray and CT) Pharmacology anamnesis: rivaroxaban, methylprednisolon, iron supplementation, PPI

3 Laboratory parameters for acceptance Urea (1,7-8,3 mmol/l) 11,3 Creatinine ( µmol/l) 299 Hemoglobin ( g/l) 78 Thrombocytes ( x10 9 /l) 49 LDH (2,2-3,2 µkat/l) 3,81 Free Hemoglobin (0-50 mg/l) 58 Haptoglobin (0,3-0,8 g/l) 1,3 Schistocytes 5 Proteinuria (g/l) 0,78 Positive LAC (112,8s), ACLA (737U/ml), B2Gl (4263U/ml) Reduction of complement (C3 0,77g/l, C4 pod 0,06g/l) Positive anti-dsdna 64 IU/ml, ANUC 64 IU/ml Negative ANA, ENA, RF, anti-ccp Normal ADAMTS 13

4 Working diagnose?

5 Differential diagnose of trombotic microangiopaties CAPS TTP/HUS HELLP Sepsis DIC HIT Anamnesis APS/SLE Malignancy/diarrhe a/aps/sle Gravidity Infection Infection/ malignity Treatment of heparine Clinical manifestation 3 and more organs in 1 week Hemolysis Thrombocytopenia Renal failure Edema Hypertension Thrombocytopeni a Hepatopathy Infection Bleeding Trombosis Thrombosis Bleeding Trombosis Large/ Small vessels Small vessels Small vessels Large/ Small vessels Small vessels Large/ Small vessels AutoAb apl Anti-ADAMTS-13 (ahus) no no no anti-hp4 Schistocytes yes yes rare rare rare rare Fibrinogen normal/ increased normal/ increased normal/ increased normal/ low normal/ low normal/ increased Cervera R., Autoimmunity Rev, 2014

6 Trombotic trombocytopenic purpura X Hemolyc uremic syndrome?

7 HUS criteria Thrombocytopenia - below 150x10 9 /l or a decrease of 25% compared to a baseline value Microangiopathic hemolytic anemia - Nonimmunologic hemolysis (anemia, bilirubin, LDH, haptoglobin) with fragmentation of erythrocytes (schistocytes) in blood count - 2 and more schistocytes in the microscopic field in 100fold magnification Ryšavá R. Hemolyticko-uremický syndrom a nové možnosti léčby. ZDN 2013 Burns ER1, Lou Y, Pathak A. Am J Hematol Jan;75(1):

8 HUS Organ manifestation - Kidney: acute or chronic x around 17% of patients have normal renal functions with little proteinuria or hematuria - CNS: stroke, cranial nerve palsy, change of psychomotor speed etc. - GIT: diarrhea, abdominal pain, vomitting, pacreatitis, hepatopathy, etc. - KV complications: IM, hypertension, heart failure, cardiomyopathy, etc. - Necrosis and skin purpura, lung bleeding, eye complications

9 What is the first line therapy for HUS?

10 Our therapy Plasmapheresis (5x) Pulses of corticosteroids (1g Methylprednisolon 4x) Substitution of erythrocytes 1st pulse of cyclophosphamide

11 TTP/HUS therapy * Specific Anticoagulation Corticosteroids Plasmapheresis IVIG Immunosuppressives Biological therapy * Treatment of trigger factors * Nonspecific Hemodialysis Artificial ventilation Ionotropics Antihypertension therapy PPI * Profylactic Treatment of infection Anticoagulation therapy (APS) surgery gravidity Relapse of SLE Polito M. Jornal Brasileiro dle Nefrologia 2010 Cervera R., Autoimmunity Rev, 2014 Cervera R., Curr Rheumatol Rep, 2010

12 Laboratory parameteres for acceptance Urea (mmol/l) 11,3 Creatinine (µmol/l) 299 Hemoglobin (g/l) 78 Thrombocytes (x10 9 /l) 49 LDH (µkat/l) 3,81 Free Hemoglobin (mg/l) 58 Haptoglobin (g/l) 1,3 Schistocytes 5 Proteinuria (g/l) 0,78 For release 8, ,8 40 0,8 3 Positive LAC (112,8s), ACLA (737U/ml), B2Gl (4263U/ml) Reduction of complement (C3 0,77g/l, C4 pod 0,06g/l) Positive anti-dsdna 64 IU/ml, ANUC 64 IU/ml Negative ANA, ENA, RF, anti-ccp Negative ADAMTS 13

13 Plasmapheresis The first line therapy It should be performed daily untill stabilization of the value of platelets 3 and hemoglobin LDH before 3 rd plasmapheresis/ldh before 1 st plasmapheresis: 0,6 marker (sensitivity 0,96, specificity 0,83) 2 - Ratio of our patient: 0,7 Mortality declined after treatment including plasmapheresis from 50% to 25% 1 There are no randomised controlled trials evaluating interventions for secondary (atypical) HUS 1 Ruggenenti P, Kidney Int 2001; 2 Haas M, Clin Nephrol 2002; 3 Roberts AW,. J Clin Apher 1991;

14 2nd hospitalization On January 2015 she was hospitalized at the Clinic of pneumology Bronchoscopy BAL Conclusion: Suspected pulmonary involvement in systemic disease Then the patient was hospitalized planned to submit a second pulse of cyclophosphamide Clinically asymptomatic, tiredness, state with a history of viral infection

15 Therapy Pulses of corticosteroids (1g Methylprednisolon 5x) Substitution of erythrocytes Intravenous immunoglobulines 0,4g/kg (4 days) Plasmapheresis (5x)

16 Laboratory parameters for acceptance Urea (mmol/l) 21,6 Creatinine (µmol/l) 363 Hemoglobin (g/l) 61 Thrombocytes (x10 9 /l) 74 LDH (µkat/l) 3,9 Free Hemoglobin (mg/l) 40 Haptoglobin (g/l) 1,2 Schistocytes 3 Proteinuria (g/l) 3,2 For release 12, , ,8 2 5/15 7, ,8 40 0,7 2 1,2

17 Diagnostic summary Systemic lupus erythematodes with medium immunological activity Secondary antiphospholipid syndrome Secondary hemolyc-uremic syndrome with renal disease

18 Antiphospholipid syndrome = 3 TROMBOTIC MANIFESTATION +/OR SPECIFIC COMPLICATION OF GRAVIDITY PERSISTENT POZITIVITY apl APS Wilson WA Arthritis Rheum 1999, 42, 1309 Miyakis S J Tromb Haemost 2006, 4, 295

19 Trombotic microangiopathy within APS TTP/HUS 33% Catastrophic APS 23% Acute renal failure 15% Malign hypertension 13% HELLP syndrome 4% Espinosa G, Ann Rheum Dis, 63, 2004 McNeil Adv Immunol 1991, 49, 1993 Diz Kucukkaya R. Blood 2001, 989, 1760

20 Antiphospholipid syndrome, trombotic microangiopathy - TTP/HUS, renal biopsy. You can see two glomeruluses, capillary colaps, endothelial edema, ischemic injury, fibrin trombus. 200fold magnification.

21 Thank you for your attention

Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature

Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature Mouhanna Abu Ghanimeh 1, Omar Abughanimeh 1, Ayman Qasrawi 1, Abdulraheem

More information

Hemolytic uremic syndrome: Investigations and management

Hemolytic uremic syndrome: Investigations and management Hemolytic uremic syndrome: Investigations and management SAWAI Toshihiro M.D., Ph.D. Department of Pediatrics, Shiga University of Medical Science Otsu, JAPAN AGENDA TMA; Thrombotic micro angiopathy STEC-HUS;

More information

What is meant by Thrombotic Microangiopathy (TMA)?

What is meant by Thrombotic Microangiopathy (TMA)? What is meant by Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (TMA) is a group of disorders characterized by injured endothelial cells, microangiopathic hemolytic anemia (MAHA), with its

More information

Most Common Hemostasis Consults: Thrombocytopenia

Most Common Hemostasis Consults: Thrombocytopenia Most Common Hemostasis Consults: Thrombocytopenia Cindy Neunert, MS MSCS Assistant Professor, Pediatrics CUMC Columbia University TSHNA Meeting, April 15, 2016 Financial Disclosures No relevant financial

More information

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial) Preamble: A confirmed diagnosis of atypical hemolytic uremic syndrome (ahus) is required for eculizumab funding. The information below is to provide clinicians with context for how a diagnosis of ahus

More information

HEME 10 Bleeding Disorders

HEME 10 Bleeding Disorders HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional

More information

Thrombotic Microangiopathies (TMA) / TTP/HUS/αHUS Pathology & Molecular. Genetics

Thrombotic Microangiopathies (TMA) / TTP/HUS/αHUS Pathology & Molecular. Genetics Thrombotic Microangiopathies (TMA) / TTP/HUS/αHUS Pathology & Molecular Genetics Helen Liapis, M.D. Senior Consultant Arkana Labs Professor of Pathology & Immunology. retired Washington University School

More information

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Things to never miss in the office Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Presenter Disclosure Faculty / Speaker s name: Brett Houston / Leonard Minuk Relationships with commercial

More information

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES ALDO E CELE DACCO

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES ALDO E CELE DACCO ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CENTRO MARIO DI NEGRI RICERCHE INSTITUTE CLINICHE FOR PHARMACOLOGICAL PER LE MALATTIE RESEARCH RARE CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES

More information

A 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis).

A 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis). A 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis). He was found to have severe kidney injury requiring

More information

1. INSTRUCTIONS 2. DEFINITION OF HUS

1. INSTRUCTIONS 2. DEFINITION OF HUS CQ_IBK_aHUS_01 / version 25/11/09 European Paediatric Research Group for HUS and related disorders Case questionnaire for diarrhoea negative/vtec (STEC) negative cases acute phase 1. INSTRUCTIONS Please

More information

Soliris (eculizumab) DRUG.00050

Soliris (eculizumab) DRUG.00050 Market DC Soliris (eculizumab) DRUG.00050 Override(s) Prior Authorization Approval Duration 1 year Medications Soliris (eculizumab) APPROVAL CRITERIA Paroxysmal Nocturnal Hemoglobinuria I. Initiation of

More information

monoclonal gammopathy of undetermin Citation Rheumatology international, 33(1),

monoclonal gammopathy of undetermin Citation Rheumatology international, 33(1), NAOSITE: Nagasaki University's Ac Title Author(s) Renal thrombotic microangiopathies/ in a patient with primary Sjögren's monoclonal gammopathy of undetermin Koga, Tomohiro; Yamasaki, Satoshi; Atsushi;

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute lung injury (ALI) transfusion-related, 363 372. See also Transfusion-related acute lung injury (TRALI) ALI. See Acute lung injury

More information

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch A 60 year old woman with altered mental status and thrombotic microangiopathy Josh Veatch Previously healthy 60 year old woman 2 3 months of fatigue following a URI, transient episodes being out of it

More information

Atypical Subacute Recurrence of Catastrophic Antiphospholipid Syndrome in a Japanese Female Patient

Atypical Subacute Recurrence of Catastrophic Antiphospholipid Syndrome in a Japanese Female Patient CASE REPORT Atypical Subacute Recurrence of Catastrophic Antiphospholipid Syndrome in a Japanese Female Patient Masanobu Horikoshi 1, Shigeko Inokuma 1, Erika Matsubara 1, Yasunori Honda 1, Rika Okada

More information

Review Article. Catastrophic Antiphospholipid Syndrome. Introduction. Etiopathogenesis. Man-Chi Leung and Woon-Leung Ng

Review Article. Catastrophic Antiphospholipid Syndrome. Introduction. Etiopathogenesis. Man-Chi Leung and Woon-Leung Ng Review Article Catastrophic Antiphospholipid Syndrome Man-Chi Leung and Woon-Leung Ng Abstract: Keywords: The catastrophic antiphospholipid syndrome is a potentially life threatening rheumatological condition

More information

Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura

Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura Kristen Knoph, PharmD, BCPS PGY2 Pharmacotherapy Resident Pharmacy Grand Rounds April 25, 2017 2016 MFMER slide-1 Objectives

More information

Antiphospholipid Antibody Syndrome: Management Issues for the Hematologist

Antiphospholipid Antibody Syndrome: Management Issues for the Hematologist Antiphospholipid Antibody Syndrome: Management Issues for the Hematologist Wisconsin Institute of Discovery Karen Rossi/Bristol-Myers Squibb Morey A. Blinder, MD Washington University, St. Louis, MO March

More information

Disorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome.

Disorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome. Disorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome. Azotemia and Urinary Abnormalities Disturbances in urine volume oliguria, anuria, polyuria Abnormalities of urine sediment red

More information

Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria

Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Farjah H AlGahtani Associate professor,md,mph Leukemia,Lymphoma in adolescent,thromboembolic

More information

Lupus as a risk factor for cardiovascular disease

Lupus as a risk factor for cardiovascular disease Lupus as a risk factor for cardiovascular disease SØREN JACOBSEN Department Rheumatology, Rigshospitalet Søren Jacobsen Main sponsors: Gigtforeningen Novo Nordisk Fonden Rigshospitalet Disclaimer: Novo

More information

New insights in thrombotic microangiopathies : TTP and ahus

New insights in thrombotic microangiopathies : TTP and ahus New insights in thrombotic microangiopathies : TTP and ahus Dr Catherine LAMBERT Hematology Cliniques universitaires Saint-Luc Catherine.lambert@uclouvain.be New insights in thrombotic microangiopathies

More information

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Mark Cunningham,MD Director, Hematology Laboratory Department of Pathology University of Kansas Medical Center College of American Pathologists

More information

Mortality in the Catastrophic Antiphospholipid Syndrome

Mortality in the Catastrophic Antiphospholipid Syndrome ARTHRITIS & RHEUMATISM Vol. 54, No. 8, August 2006, pp 2568 2576 DOI 10.1002/art.22018 2006, American College of Rheumatology Mortality in the Catastrophic Antiphospholipid Syndrome Causes of Death and

More information

Renal failure and thrombocytopaenia? Don t forget TTP/HUS. Jonathan Wala Nephrologist

Renal failure and thrombocytopaenia? Don t forget TTP/HUS. Jonathan Wala Nephrologist Renal failure and thrombocytopaenia? Don t forget TTP/HUS Jonathan Wala Nephrologist Thrombotic microangiopathies Disorders characterized by: thrombocytopaenia microangiopathic haemolytic anaemia (MAHA)

More information

DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL

DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL Rare but fatal disease if unrecognized and untreated Incidence about 1: 1 million in the USA Female preponderance of 2:1 Part

More information

Approccio morfologico alle microangiopatie trombotiche

Approccio morfologico alle microangiopatie trombotiche Approccio morfologico alle microangiopatie trombotiche Gina Zini Polo Oncologia e Ematologia Policlinico A. Gemelli Università Cattolica S. Cuore - Roma 1 Thrombotic microangiopathies Occlusive microangiopathic

More information

Additional file 2: Details of cohort studies and randomised trials

Additional file 2: Details of cohort studies and randomised trials Reference Randomised trials Ye et al. 2001 Abstract 274 R=1 WD=0 Design, numbers, treatments, duration Randomised open comparison of: (45 patients) 1.5 g for 3, 1 g for 3, then 0.5 to 0.75 g IV cyclophosphamide

More information

Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL

Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL CASE HISTORY 4 yrs old previously well boy Born to 2 nd degree consanguinity Fever x 5 days

More information

TMA in HUS and TTP: new insights

TMA in HUS and TTP: new insights TMA in HUS and TTP: new insights Daan Dierickx University Hospitals Leuven, Department of Hematology, Belgium 20th Annual Meeting Belgian Society on Thrombosis and Haemostatis Antwerpen, 22 th November

More information

GOODPASTURE'S SYNDROME WITH CONCOMITANT IMMUNE COMPLEX MIXED MEMBRANOUS AND PROLIFERATIVE GLOMERULONEFRITIS

GOODPASTURE'S SYNDROME WITH CONCOMITANT IMMUNE COMPLEX MIXED MEMBRANOUS AND PROLIFERATIVE GLOMERULONEFRITIS GOODPASTURE'S SYNDROME WITH CONCOMITANT IMMUNE COMPLEX MIXED MEMBRANOUS AND PROLIFERATIVE GLOMERULONEFRITIS VESNA JURČIĆ 1, ANDREJA ALEŠ RIGLER 2, INSTITUTE OF PATHOLOGY, FACULTY OF MEDICINE, UNIVERSITY

More information

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction

More information

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests Minor Allergic (Urticarial) Urticaria, pruritis, flushing, rash If skin reaction only and mild hives/ rash

More information

* Renal insufficiencies

* Renal insufficiencies Thrombotic Thrombocytopenic Purpura Behzad Poopak, DCLS PhD. Tehran medical Branch Islamic Azad university bpoopak@yahoo.com Case Summary Ms. X, a 35-year year-old woman Complained of weakness, low grade

More information

M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.

M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic

More information

Membranous nephropathy. By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University

Membranous nephropathy. By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University Membranous nephropathy By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University Membranous nephropathy Definition: Immune complex glomerular disease in which immune deposits of IgG and complement

More information

Year 2004 Paper one: Questions supplied by Megan

Year 2004 Paper one: Questions supplied by Megan QUESTION 53 Endothelial cell pathology on renal biopsy is most characteristic of which one of the following diagnoses? A. Pre-eclampsia B. Haemolytic uraemic syndrome C. Lupus nephritis D. Immunoglobulin

More information

Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience

Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience Ala M. AlHeresh MD* ABSTRACT Objectives: To study the characteristics of Systemic Lupus Erythematosus in Jordan and

More information

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016 Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016 Case report 20 months old girl Israeli Arab Muslim family, consanguineous marriage

More information

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J. Making Room for Rheumatology James J. Nocton, MD Disclosures I have nothing to disclose Rheumatic Diseases of Childhood Juvenile Idiopathic Arthritis (JIA) Systemic Lupus Erythematosus (SLE) Juvenile Dermatomyositis

More information

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA Contemporary perspectives and initial management of pediatric ITP William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA Case Presentation 5 year old female Bruises on trunk, extremities

More information

Online Supplementary Data. Country Number of centers Number of patients randomized

Online Supplementary Data. Country Number of centers Number of patients randomized A Randomized, Double-Blind, -Controlled, Phase-2B Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients with Sepsis and Suspected Disseminated Intravascular

More information

The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement

The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement Rymarz and Niemczyk BMC Nephrology (2018) 19:132 https://doi.org/10.1186/s12882-018-0928-z CASE REPORT Open Access The complex treatment including rituximab in the Management of Catastrophic Antiphospholid

More information

Situaciones estresantes en el lupus

Situaciones estresantes en el lupus Situaciones estresantes en el lupus Munther A Khamashta MD FRCP PhD Director: Lupus Research Unit Barcelona, Noviembre 2008 What is Lupus? Lupus is a neurological disease and sometimes affects other organs

More information

THE KIDNEY AND SLE LUPUS NEPHRITIS

THE KIDNEY AND SLE LUPUS NEPHRITIS THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS

More information

Hematologic changes in systemic diseases. Chittima Sirijerachai

Hematologic changes in systemic diseases. Chittima Sirijerachai Hematologic changes in systemic diseases Chittima Sirijerachai Systemic diseases Infection Renal diseases Liver diseases Connective tissue diseases Malignancy Anemia of chronic disease (ACD) Chronic infections:

More information

Thrombotic Microangiopathies

Thrombotic Microangiopathies Thrombotic Microangiopathies ASH/San Antonio Breast Cancer Symposium Review James N. George March 14, 2015 Thrombotic Microangiopathies (TMA): Everything you need to know from 5 patient stories Thrombotic

More information

Heme (Bleeding and Coagulopathies) in the ICU

Heme (Bleeding and Coagulopathies) in the ICU Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related

More information

Fußzeile (Titel der Präsentation) 1. Thrombotic Microangiopathy: The German Experience 4. Conflictof interest: none

Fußzeile (Titel der Präsentation) 1. Thrombotic Microangiopathy: The German Experience 4. Conflictof interest: none Thrombotic Microangiopathy: The German Experience 3 Nephropathology Section, Institute of Pathology, Hamburg, Germany Agenda 1. Difficulties in the diagnosis TMA 2. Previous efforts to reach consensus

More information

Clinical Study A Study on Clinical and Pathologic Features in Lupus Nephritis with Mainly IgA Deposits and a Literature Review

Clinical Study A Study on Clinical and Pathologic Features in Lupus Nephritis with Mainly IgA Deposits and a Literature Review Clinical and Developmental Immunology Volume 2013, Article ID 289316, 5 pages http://dx.doi.org/10.1155/2013/289316 Clinical Study A Study on Clinical and Pathologic Features in Lupus Nephritis with Mainly

More information

ONE of the following:

ONE of the following: Medical Coverage Policy Belimumab (Benlysta) EFFECTIVE DATE: 01 01 2012 POLICY LAST UPDATED: 11 21 2017 OVERVIEW Belimumab (Benlysta ) is indicated for the treatment of adult patients with active, autoantibody-positive,

More information

Some renal vascular disorders

Some renal vascular disorders Some renal vascular disorders Introduction Nearly all diseases of the kidney involve the renal blood vessels secondarily We will discuss: -Hypertension (arterionephrosclerosis in benign HTN & hyperplastic

More information

TMA CASE STUDY. Pamela Harmon, RN & Keturah Tomlin, RN Toronto General Hospital Apheresis Unit

TMA CASE STUDY. Pamela Harmon, RN & Keturah Tomlin, RN Toronto General Hospital Apheresis Unit TMA CASE STUDY Pamela Harmon, RN & Keturah Tomlin, RN Toronto General Hospital Apheresis Unit Cumulative fraction of patients free of events ahus is a catastrophic disease that can result in sudden & progressive

More information

Antiphospholipid Syndrome: It s Far More Than You Think

Antiphospholipid Syndrome: It s Far More Than You Think Antiphospholipid Syndrome: It s Far More Than You Think Richard Furie, MD Chief, Division of Rheumatology Northwell Health Professor of Medicine Zucker School of Medicine at Hofstra/Northwell Richard Furie,

More information

Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) Case presentations and topic discussion The Rheumatology Unit UMMC experience

Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) Case presentations and topic discussion The Rheumatology Unit UMMC experience Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) Case presentations and topic discussion The Rheumatology Unit UMMC experience References Sanna G, Bertolaccini ML. Neuropsychiatric manifestations

More information

Dr P Sigwadi 30 May 2012

Dr P Sigwadi 30 May 2012 Dr P Sigwadi 30 May 2012 Introduction Haematuria Positive blood on urine dipstick 5 red blood cells/ microliter of urine Prevalence Gross haematuria ( macroscopic) 0.13 % Microscopic- 1.5% Haematuria +

More information

Benlysta (belimumab) Prior Authorization Criteria Program Summary

Benlysta (belimumab) Prior Authorization Criteria Program Summary Benlysta (belimumab) Prior Authorization Criteria Program Summary This prior authorization applies to Commercial, NetResults A series, NetResults F series and Health Insurance Marketplace formularies.

More information

1) unexplained microangiopathic hemolytic anemia (Coombs negative anemia),

1) unexplained microangiopathic hemolytic anemia (Coombs negative anemia), Ravi Sarode, MD Consensus Process The TTP-CC subcommittee developed 7 key questions Sent to the 7 speakers for electronic voting in Yes or No format Will be published in JCA soon Q.1 Untreated TTP carries

More information

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS LUPUS 101 LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS SLE SUBSETS SUBACUTE CUTANEOUS LUPUS DRUG INDUCED LUPUS NEONATAL LUPUS LATE ONSET LUPUS ANTI-PHOSPHOLIPID

More information

Kidney disease associated with autoimmune disease

Kidney disease associated with autoimmune disease Kidney disease associated with autoimmune disease Masaomi Nangaku Division of Nephrology and Endocrinology the University of Tokyo Graduate School of Medicine, Japan M-type Phospholipase A2 Receptor as

More information

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D.

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden

More information

Journal of Nephropathology

Journal of Nephropathology DOI: 10.12860/jnp.2014.03 J Nephropathol. 2014; 3(1): 9-17 Journal of Nephropathology Catastrophic antiphospholipid syndrome: a clinical review Ali Nayer 1,*, Luis M. Ortega 2 1 Division of Nephrology

More information

Thrombotic thrombocytopenic purpura: 2008 Update

Thrombotic thrombocytopenic purpura: 2008 Update MEDICAL GRAND ROUNDS CME CREDIT MARK A. CROWTHER, MD Director, Division of Hematology, McMaster University, Hamilton, Ontario, Canada JAMES N. GEORGE, MD Hematology-Oncology Section, Department of Medicine,

More information

UKITP INITAL INFORMATION SHEET (2.4)

UKITP INITAL INFORMATION SHEET (2.4) UKITP INITAL INFORMATION SHEET (2.4) Barts Health NHS Trust The Royal London Hospital Pathology and Pharmacy Building 80 Newark Street, London E1 2ES Centre for Haematology Institute of and Molecular Science

More information

Case Report Catastrophic Antiphospholipid Syndrome

Case Report Catastrophic Antiphospholipid Syndrome Case Reports in Rheumatology Volume 2016, Article ID 4161439, 4 pages http://dx.doi.org/10.1155/2016/4161439 Case Report Catastrophic Antiphospholipid Syndrome Rawhya R. El-Shereef, 1 Zein El-Abedin, 2

More information

Atypical IgA Nephropathy

Atypical IgA Nephropathy Atypical IgA Nephropathy Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA XXXIII Chilean Congress of Nephrology, Hypertension and Transplantation Puerto Varas, Chile October 6, 2016 IgA

More information

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT HISTOPATHOLOGIC DISORDERS AFFECTING THE ALLOGRAFT OTHER THAN REJECTION RECURRENT DISEASE DE NOVO DISEASE TRANSPLANT GLOMERULOPATHY Glomerular Non-glomerular

More information

HUS and TTP Testing. Kenneth D. Friedman, M.D. Director, Hemostasis Reference Lab BloodCenter of Wisconsin, Milwaukee WI

HUS and TTP Testing. Kenneth D. Friedman, M.D. Director, Hemostasis Reference Lab BloodCenter of Wisconsin, Milwaukee WI HUS and TTP Testing Kenneth D. Friedman, M.D. Director, Hemostasis Reference Lab BloodCenter of Wisconsin, Milwaukee WI Disclosures Relevant Financial Relationships Consultant: Ablynx, Bayer, CSL Behring,

More information

Case Report Antiphospholipid Syndrome: Multiple Manifestations in a Single Patient A High Suspicion Is Still Needed

Case Report Antiphospholipid Syndrome: Multiple Manifestations in a Single Patient A High Suspicion Is Still Needed Hindawi Case Reports in Medicine Volume 2017, Article ID 5797041, 4 pages https://doi.org/10.1155/2017/5797041 Case Report Antiphospholipid Syndrome: Multiple Manifestations in a Single Patient A High

More information

Case Studies. Scleroderma Renal Crisis or Thrombotic Thrombocytopenic Purpura: Seeing Through the Masquerade. Patient 1

Case Studies. Scleroderma Renal Crisis or Thrombotic Thrombocytopenic Purpura: Seeing Through the Masquerade. Patient 1 Scleroderma Renal Crisis or Thrombotic Thrombocytopenic Purpura: Seeing Through the Masquerade Emily Keeler, DO, 1* Gloria Fioravanti, DO, FACP, 1 Bensson Samuel, MD, PG Dip, 1 Santo Longo, MD 2 Lab Med

More information

Thrombotic Microangiopathy secondary to Malignant Hypertension presenting as acute Kidney injury-a Case Report

Thrombotic Microangiopathy secondary to Malignant Hypertension presenting as acute Kidney injury-a Case Report ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 640-644 http://www.ijcmas.com Case Study Thrombotic Microangiopathy secondary to Malignant Hypertension presenting as acute Kidney injury-a Case Report Sandeep

More information

Patologie da attivazione del complemento G.F.Ferraccioli Istituto di Reumatologia e Scienze Affini Facolta di Medicina Universita Cattolica del sacro

Patologie da attivazione del complemento G.F.Ferraccioli Istituto di Reumatologia e Scienze Affini Facolta di Medicina Universita Cattolica del sacro Patologie da attivazione del complemento G.F.Ferraccioli Istituto di Reumatologia e Scienze Affini Facolta di Medicina Universita Cattolica del sacro Cuore Roma Roma 19.02.2016 TMA: complement disorders

More information

ACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS. Myriam Farah, MD, FRCPC

ACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS. Myriam Farah, MD, FRCPC ACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS Myriam Farah, MD, FRCPC Clinical Assistant Professor Division of Nephrology, University of British Columbia November 2016 1. How to recognize acute

More information

QUICK REFERENCE Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP)

QUICK REFERENCE Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP) QUICK REFERENCE 2011 Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP) Presented by the American Society of Hematology, adapted from: The American Society of

More information

Extrarenal involvement in pediatric ahus Kosan C et al

Extrarenal involvement in pediatric ahus Kosan C et al Case Report J Ped. Nephrology 2014;2(4):154-157 http://journals.sbmu.ac.ir/jpn Atypical Hemolytic Uremic Syndrome with Severe Extrarenal Manifestations: a Case Report How to Cite This Article: KOŞAN C,

More information

Transfusion Reactions

Transfusion Reactions Transfusion Reactions From A to T Provincial Blood Coordinating Program Daphne Osborne MN PANC (C) RN We want you to know Definition Appropriate actions Classification Complete case studies Transfusion

More information

Thrombosis and emboli. Peter Nagy

Thrombosis and emboli. Peter Nagy Thrombosis and emboli Peter Nagy A thrombus is any solid object developing from the blood in vivo within the vascular system or heart. Thrombosis is hemostasis in the wrong place. Major components, forms:

More information

HENOCH SCHÖNLEIN PURPURA (VASCULAR PURPURA, ANAPHYLACTOID PURPURA) IN CHILDREN Single choice tests (SC)

HENOCH SCHÖNLEIN PURPURA (VASCULAR PURPURA, ANAPHYLACTOID PURPURA) IN CHILDREN Single choice tests (SC) HENOCH HÖNLEIN PURPURA (VAULAR PURPURA, ANAPHYLACTOID PURPURA) IN CHILDREN Single choice tests () 1. Choose the type of bleeding characteristic for the Henoch Schönlein purpura (vascular purpura, anaphylactoid

More information

Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy

Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Professeur Eric Rondeau Urgences néphrologiques et Transplantation rénale Hôpital Tenon, Paris WWA SFH

More information

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis SA-PO546 Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Johan Vande Walle, 1 Larry A. Greenbaum, 2 Camille L. Bedrosian, 3 Masayo Ogawa, 3 John F. Kincaid,

More information

Paolo Gresele Dipartimento di Medicina, Sezione di Medicina Interna e Cardiovascolare, Università di Perugia

Paolo Gresele Dipartimento di Medicina, Sezione di Medicina Interna e Cardiovascolare, Università di Perugia Le sindromi trombotiche microangiopatiche: il ruolo del laboratorio Paolo Gresele Dipartimento di Medicina, Sezione di Medicina Interna e Cardiovascolare, Università di Perugia Microangiopatie trombotiche:

More information

Diagnosis and Management of Catastrophic Antiphospholipid Syndrome: a Clinical Practice Guideline

Diagnosis and Management of Catastrophic Antiphospholipid Syndrome: a Clinical Practice Guideline Diagnosis and Management of Catastrophic Antiphospholipid Syndrome: a Clinical Practice Guideline Introduction The public comment period occurs after recommendations are formed but before a manuscript

More information

Case report Fever in a patient with ANCA-associated vasculitis

Case report Fever in a patient with ANCA-associated vasculitis Case report Fever in a patient with ANCA-associated vasculitis 73 years-old white woman PRIOR MEDICAL HISTORY *Hypertension: Enalapril, Furosemide *Dyslipidemia: Pravastatin *Ischemic heart disease: 2008

More information

A young female with catastrophic antiphospholipid syndrome

A young female with catastrophic antiphospholipid syndrome www.edoriumjournals.com case report open ACCESS A young female with catastrophic antiphospholipid syndrome Vivekanandan Senthamil Pari, Lakshmi M, Sampath Kumar, Sathyamurthy P, Sudhakar MK, Sandhya Sundaram

More information

Protocol Version 2.0 Synopsis

Protocol Version 2.0 Synopsis Protocol Version 2.0 Synopsis Title Short Title Plasma exchange and glucocorticoid dosing in anti-neutrophil cytoplasm antibody associated vasculitis: a randomized controlled trial. PEXIVAS PEXIVAS Clinical

More information

Renal Disease. Please refer to the assignment page Three online modules TBLs

Renal Disease. Please refer to the assignment page Three online modules TBLs Renal Disease Please refer to the assignment page Three online modules TBLs 1 Renal Embryology 2 Lab Tests UA CBC Enzymes Creatinine Creatinine clearance Ammonia Abs C Bx 3 BUN Creatinine Creatinine Clearance

More information

Accepted Manuscript. No more thrombotic thrombocytopenic purpura/hemolytic uremic syndrome please. Yeong-Hau H. Lien MD, PhD S (18)

Accepted Manuscript. No more thrombotic thrombocytopenic purpura/hemolytic uremic syndrome please. Yeong-Hau H. Lien MD, PhD S (18) Accepted Manuscript No more thrombotic thrombocytopenic purpura/hemolytic uremic syndrome please Yeong-Hau H. Lien MD, PhD PII: S0002-9343(18)30965-3 DOI: https://doi.org/10.1016/j.amjmed.2018.10.009 Reference:

More information

Outcome of Disseminated Intravascular Coagulation without Documented Antiphospholipid Antibody Successfully Treated with Rituximab

Outcome of Disseminated Intravascular Coagulation without Documented Antiphospholipid Antibody Successfully Treated with Rituximab Soonchunhyang Medical Science 21(2):154-158, December 2015 pissn: 2233-4289 I eissn: 2233-4297 SE REPORT Outcome of Disseminated Intravascular oagulation without Documented ntiphospholipid ntibody Successfully

More information

Primary causes: Complement dysregulation (50% of non-shiga toxin-producing E. coli ) Secondary causes:

Primary causes: Complement dysregulation (50% of non-shiga toxin-producing E. coli ) Secondary causes: General department INTRODUCTION The hemolytic uremic syndrome (HUS): microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury One of the main causes of acute kidney injury in children

More information

Rituximab. B Cell Inhibition in APS. Methods. B Cell Inhibition in APS. Disclosure 11/6/2011

Rituximab. B Cell Inhibition in APS. Methods. B Cell Inhibition in APS. Disclosure 11/6/2011 Rituximab in Antiphospholipid Syndrome (RITAPS) A Pilot Open-Label Phase II Prospective Trial for Non-Criteria Manifestations of Antiphospholipid Antibodies (NCT: 00537290) Disclosure Research Support:

More information

LAMA SHATAT TTP, ITP, DIC

LAMA SHATAT TTP, ITP, DIC TTP, ITP, DIC Reduction in platelet number (thrombocytopenia) constitutes an important cause of generalized bleeding. A count less than 100,000 platelets/μl is generally considered to constitute thrombocytopenia.

More information

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of

More information

Discussion. Case conference. Anemia. The basic evaluation of a patient newly diagnosed with anemia. Speaker : R2 趙劭倫 Supervisor : VS 林立偉

Discussion. Case conference. Anemia. The basic evaluation of a patient newly diagnosed with anemia. Speaker : R2 趙劭倫 Supervisor : VS 林立偉 Case conference Discussion Speaker : R2 趙劭倫 Supervisor : VS 林立偉 990123 The basic evaluation of a patient newly diagnosed with anemia Anemia CBC Reticulocyte count : reflects activity in the bone marrow

More information

PREGNANCY ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND ACUTE KIDNEY INJURY

PREGNANCY ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND ACUTE KIDNEY INJURY VII, 2013, 2 33 A, PREGNANCY ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND ACUTE KIDNEY INJURY M. Lubomirova Clinic of Nephrology, University Hospital Aleksandrovska So a : ( ), /HELLP, (AFLP) (TTP)

More information

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations 08/30/10 09/26/10 Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations Camila Downey S. Universidad de Chile, School of Medicine, Year VII Harvard University, School of Medicine Sept 17,

More information

Microangiopatia trombotica (MAT) e Sindrome emolitico-uremica atipica (SEUa): Basi patogenetiche, inquadramento diagnostico e principi del

Microangiopatia trombotica (MAT) e Sindrome emolitico-uremica atipica (SEUa): Basi patogenetiche, inquadramento diagnostico e principi del Microangiopatia trombotica (MAT) e Sindrome emolitico-uremica atipica (SEUa): Basi patogenetiche, inquadramento diagnostico e principi del trattamento Vincenzo Montinaro U.O. Nefrologia Azienda Ospedaliera

More information

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11 THROMBOTIC MICROANGIOPATHY Jun-Ki Park 7/19/11 TMAs are microvascular occlusive disorders characterized by systemic or intrarenal aggregation of platelets, thrombocytopenia, and mechanical injury to erythrocytes.

More information

PLASMA EXCHANGE J MANION NEPEAN HOSPITAL

PLASMA EXCHANGE J MANION NEPEAN HOSPITAL PLASMA EXCHANGE J MANION NEPEAN HOSPITAL PLASMA The fluid portion of blood Normally approx 5% body weight or 3.5L in 70kg male Clots on standing unless anticoagulated Common plasma proteins are albumin,

More information

Antiphospholipid Syndrome Handbook

Antiphospholipid Syndrome Handbook Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, Oier Ateka-Barrutia, and Munther A. Khamashta Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, MD, PhD Lupus Research Unit The Rayne

More information